381 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B Buy
Article Searches
Catalyst Biosciences: Highly Attractive Hemophilia Pipeline With Upcoming Catalysts, Yet Still Trading At Cash Value https://seekingalpha.com/article/4204833-catalyst-biosciences-highly-attractive-hemophilia-pipeline-upcoming-catalysts-yet-still?source=feed_tag_editors_picks Sep 07, 2018 - Catalyst Biosciences is a clinical-stage biotech company focused on the treatment of hemophilia.After announcing preliminary results for a Phase 1/2 trial in June, Catalyst's market capitalization fel
Wall Street Breakfast: U.S. Stocks Poised For A Breather After Yesterday's Spike https://seekingalpha.com/article/4200014-wall-street-breakfast-u-s-stocks-poised-breather-yesterdays-spike?source=feed_tag_wall_st_breakfast Aug 17, 2018 -
Stocks To Watch: Any Privacy For Tesla? https://seekingalpha.com/article/4197968-stocks-watch-privacy-tesla?source=feed Aug 11, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Pharma Stock Roundup: NVO Q2 Earnings, JNJ, AGN & AZN's Pipeline Updates in Focus http://www.zacks.com/stock/news/317383/pharma-stock-roundup-nvo-q2-earnings-jnj-agn-azns-pipeline-updates-in-focus?cid=CS-ZC-FT-317383 Aug 10, 2018 - Novo Nordisk (NVO) reports strong Q2 results. J&J (JNJ) seeks approval for new dosing regimen of multiple myeloma drug. Allergan (AGN) exercises option to buy Editas' lead ocular candidate.
Stocks making the biggest moves premarket: KORS, CVS, DIS, PZZA & more https://www.cnbc.com/2018/08/08/stocks-making-the-biggest-moves-premarket-kors-cvs-dis-pzza--more.html Aug 08, 2018 - Names on the move ahead of the open.
Lilly (LLY) Issues Update on Diabetes Drug Trulicity Label http://www.zacks.com/stock/news/312546/lilly-lly-issues-update-on-diabetes-drug-trulicity-label?cid=CS-ZC-FT-312546 Jul 20, 2018 - Lilly (LLY) updates Trulicity's label to include data from a new study on patients with type II diabetes suffering from moderate to severe chronic kidney disease.
LLY vs. NVO: Which Stock Is the Better Value Option? http://www.zacks.com/stock/news/312230/lly-vs-nvo-which-stock-is-the-better-value-option?cid=CS-ZC-FT-312230 Jul 19, 2018 - LLY vs. NVO: Which Stock Is the Better Value Option?
LLY vs. NVO: Which Stock Is the Better Value Option? http://www.zacks.com/stock/news/312246/lly-vs-nvo-which-stock-is-the-better-value-option?cid=CS-ZC--312246 Jul 19, 2018 - LLY vs. NVO: Which Stock Is the Better Value Option?
Air Pollution In Emerging Markets To Benefit Novo Nordisk https://seekingalpha.com/article/4186009-air-pollution-emerging-markets-benefit-novo-nordisk?source=feed_sector_healthcare Jul 09, 2018 - A recent study shows that the level of air pollution in an area increases the risks of the inhabitants of that area to contract type-2 diabetes. Emerging markets often do not have the pollution contro
Novo Nordisk: Obesity Crisis Continues To Get Worse - Buy The Stock Today https://seekingalpha.com/article/4179020-novo-nordisk-obesity-crisis-continues-get-worse-buy-stock-today?source=feed_sector_healthcare Jun 03, 2018 - By 2045, almost a quarter of the world's population is expected to be obese compared to 14% today. This is expected to increase the prevalence of type-2 diabetes in the general population. Novo Nordis

Pages: 123456789...39

<<<Page 4>